MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Specific Metabolic Pathways Underlie Noncommunicable Disease Multimorbidity

inBiomarkers, Drug Development, Population Health, Precision Medicine

Metabolomics helps understand shared etiologies of comorbidities, which could result in better treatments for patients.

Most prospective metabolomics studies are focused on single diseases. One in four patients, however, presents with two or more chronic conditions at the same time, referred to as multimorbidity.

A new study led by Claudia Langenberg at the MRC Epidemiology Unit, University of Cambridge  has been published in Nature Medicine aimed to understand shared etiologies among co-morbidities. The scientists integrated Metabolon’s global metabolomics technology with deep phenotypic patient data to elucidate the biochemical changes that mark and may cause multiple incident diseases at the same time. The research team analyzed the levels of over 1,000 metabolites in the plasma of more than 11,000 participants from the European Prospective Investigation into Cancer (EPIC)-Norfolk study. Comprehensive profiling of blood metabolites is a powerful approach to identify biomarkers and signatures of disease, many of which share common biochemical perturbations across diverse pathways.

A detailed analysis of the human metabolome in so many individuals offered a comprehensive readout of human physiology that enabled to characterize pathways associated with and across 27 incident noncommunicable diseases. The findings showed that there are metabolic pathways that underpin multiple chronic conditions that we know associate and move together in the clinic like obesity and type II diabetes and cardiometabolic disorders. But, through this work, other less well-described correlative conditions like stomach cancer and Deep Vein Thrombosis (DVT) or colon cancer and Chronic obstructive pulmonary disease (COPD) were found to occur simultaneously as well.

Such metabolic insights suggest that there could be potential common mechanisms or processes that could inform on how to treat simultaneously occurring chronic conditions in patients.

This approach of understanding pathways of disease will be central to develop new models to improve prediction of individuals at risk and enable their appropriate clinical management.

Learn how Metabolon can help accelerate your research, contact us today.

Back to the Blog
  • Metabolomics to Investigate the Immuno-metabolism and Inflamm-aging Triggered by Viral Infections
    Previous PostMetabolomics to Investigate the Immuno-metabolism and Inflamm-aging Triggered by Viral Infections
  • Next PostMetabolon’s Validation of Dried Blood Spot (DBS) Cards for Metabolomics Analysis
    Metabolomics to Investigate the Immuno-metabolism and Inflamm-aging Triggered by Viral Infections

Related Posts

Event: Precision Medicine World Conference (PMWC)
Events

Event: Precision Medicine World Conference (PMWC)

Webinar: Integrated Multiomic Analysis for Disease
Events

Webinar: Integrated Multiomic Analysis for Disease

Metabolomics in drug discovery: The missing piece for multi-omics data
Events

Metabolomics in drug discovery: The missing piece for multi-omics data

How Metabolomics Can Raise the Bar in Drug Development
Drug Development Working with Metabolon

How Metabolomics Can Raise the Bar in Drug Development

Metabolon Announces Chief Financial Officer Transition
Company News

Metabolon Announces Chief Financial Officer Transition

Lunch and Learn: Applications of Metabolomics in Microbiome Research
Events

Lunch and Learn: Applications of Metabolomics in Microbiome Research

Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen
Company News

Metabolon to Power Metabolomic Enriched Population Health Studies at FinnGen

Overcoming the Limitations of Mass Spectrometry Across Datasets
Blog Capabilities Working with Metabolon

Overcoming the Limitations of Mass Spectrometry Across Datasets

Leading medical centers leverage metabolomics to better understand the impact of lactation on birth and maternal outcomes
Company News

Leading medical centers leverage metabolomics to better understand the impact of lactation on birth and maternal outcomes

Bile acid quantification provides insight into the mechanism of action for the treatment of NASH
Biomarkers Drug Development

Bile acid quantification provides insight into the mechanism of action for the treatment of NASH

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Quality Assurance
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events
  • Publications

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy